Geno

What Geno does

Geno Pharmaceuticals Pvt. Ltd. is an Indian pharmaceutical manufacturer founded in 1975 and headquartered in Mapusa, Goa, operating as a privately held, family-controlled company under the Salgaocar family. It ranks among the top 70 pharmaceutical companies in India and employs between 1,001 and 5,000 people. Its operations span formulation, manufacturing, marketing, and export of generic and specialty pharmaceutical products in dosage forms including tablets, capsules, liquids, and semisolids, supported by a state-of-the-art R&D facility in Goa with HPLC, GC, FTIR, and ICH-stability capabilities, and additional manufacturing capacity under construction in Indore.

The company is organised into four operating divisions: Geno Shakti (general pharmaceuticals including Cypon, Genozyme, and Fusigen), Geno Shaurya (trauma, orthopaedic, and pain management — launched 2016), Clean Care (dermatology and derma-nutraceuticals — launched 2000), and Geno Vet (animal health). Its commercial model rests on three revenue streams: branded domestic pharmaceutical sales, contract development and manufacturing (CDMO) services for regulated-market clients in the UK, Europe, Australia, and New Zealand, and dossier licensing. Domestically it sells through 24 depots, more than 1,298 distributors and stockists, and a 680-person field sales force; internationally it serves 25+ countries in Africa, South/Southeast Asia, the GCC, and select regulated markets via distributor and direct-to-market models.

Key certifications include WHO-GMP (1998), ISO 9001:2008, and EU-GMP (2018, with UK-MHRA-compliant oral-dosage capability), which together enable both government-tender access in India and regulated-market CDMO contracts abroad. The company is privately held with no disclosed funding rounds, no institutional investors identified, and no public revenue figures; growth is being pursued through capacity expansion, portfolio diversification, and export/CDMO build-out.

Name

Geno

Legal name

Geno Pharmaceuticals Pvt. Ltd.

Website

https://genopharma.com

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Geno Pharmaceuticals is a privately held Indian pharma manufacturer (founded 1975, Goa) operating four divisions — Shakti, Shaurya, Clean Care, and Vet — that sells branded generics domestically via 1,298+ distributors and a 680-person field force, and offers CDMO services to regulated markets across 25+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Pharmaceutical manufacturing
• Generic formulations
• Contract manufacturing services
• Topical antibiotic formulations
• Derma-nutraceutical products

Headquarters

HQ city

Mapuca

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Sale of proprietary pharmaceutical products across multiple therapeutic categories including antibiotics, analgesics, antacids, multivitamins, and specialty medications through domestic distribution network and international markets.
2. Contract Manufacturing (CMO/CDMO): Contract Development and Manufacturing Organization providing pre-formulation and formulation development, analytical development, ICH stability studies, and cGMP manufacturing for global pharmaceutical industry. Specializes in differentiated products, complex generics, fixed-dose combinations, and OTC products.
3. Dossier Licensing: Out-licensing of proprietary product dossiers to international partners and in-licensing of novel products from partners to expand portfolio and market reach.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Geno Pharmaceuticals manufactures, markets, and distributes a broad proprietary pharmaceutical portfolio organized through four divisions (Geno Shakti, Geno Shaurya, Clean Care, Geno Vet) covering therapeutic areas such as appetite stimulation, antibiotics, analgesia, dermatology, vertigo, gout, derma-nutraceuticals, and animal health. The company also operates as a Contract Development and Manufacturing Organization (CDMO), providing pre-formulation, formulation development, analytical development, ICH stability studies, and cGMP manufacturing for clients in regulated markets including the UK, Europe, Australia, and New Zealand.

Product overview

Geno Pharmaceuticals Pvt. Ltd. is a pharmaceutical company offering a multi-division portfolio structured as platform-plus-divisions architecture. The company operates through four main divisions: Geno Shakti (general pharmaceuticals with products like Cypon, Genozyme, Genoplex), Geno Shaurya (trauma and pain management including Fusigen line, Vertigon, Myolaxin), Clean Care (dermatological and derma-nutraceutical products including ORAFACE, XFOLIA hair care, and skincare), and Geno Vet (animal health). The company also operates as a Contract Development and Manufacturing Organization (CDMO) serving regulated markets globally.

Differentiator

Problem solved

Functional benefit

Brands

• Geno Shakti Division: Lead pharmaceutical division focused on affordable healthcare and medications including Cypon, Fusigen, Myolaxin, Genozyme, Genoplex L, and other brands across therapeutic areas.
• Geno Shaurya Division
• Clean Care
• Geno Vet Division
• Geno Sports Club
• Dainty Delights

Products and services

• Geno Shakti Division Lead pharmaceutical division offering multi-spectrum medicines including appetite stimulants (Cypon), topical antibiotics (Fusigen), pain relievers (Myolaxin), digestive enzyme preparations (Genozyme), and multivitamin formulations, focused on affordable medicines for every patient.
• Geno Shaurya Division Trauma care division focused on pain management and affordable medications, including topical antibiotics (Fusigen Spray, Fusigen Tulle), analgesics (Myolaxin-D), gout management (BENCID), vertigo treatment (Vertigon, Betahist), and bronchodilators.
• Clean Care Division Dermatological division offering skincare, hair care, and derma-nutraceutical products including acne treatments (ORAFACE), anti-aging formulations (YAWARA, EVALITE), hair loss solutions (XFOLIA series), moisturizers (GENOMOIST), and sunscreens (XUV).
• Geno Vet Division Veterinary division focused on animal health and well-being with a product range designed for livestock animals, farmers, and field veterinarians, leveraging Geno's Mapusa, Goa manufacturing capability.
• Fusigen Ointment Topical antibiotic ointment containing Sodium Fusidate 2% w/w, positioned as a first-choice topical antibiotic for skin infections with faster improvement versus Mupirocin and Nadifloxacin.
• Fusigen Spray India's first alcohol-based antibiotic spray for surgical site infection prevention, providing superior antibiotic coverage including MRSA, Staph. Aureus, and E. Coli.
• Vertigon Vertigo treatment brand containing Cinnarizine 25mg, marketed for 32 years to improve microcirculation of the inner ear without GI complaints, fatigue, or altered taste common to Betahistine.
• Cypon No.1 brand of Cyproheptadine for 34 years as an appetite stimulant, available in multiple dosage forms including Syrup, Drops, Tablets, and Capsules, for loss of appetite across all age groups including geriatric patients.
• Genozyme Digestive enzyme preparation containing Pepsin and Fungal Diastase in syrup and capsule forms, optimizing breakdown of fats, carbohydrates, and proteins with a non-alcoholic base for uniform efficacy.
• ORAFACE Acne treatment gel containing Clindamycin Phosphate 1% w/w combined with Tetrahydrocurcumin, for mild to moderate inflamed acne with anti-inflammatory properties.
• XFOLIA NX Next-generation Minoxidil serum for male and female pattern hair loss, available in 2%, 5%, and 5% with Finasteride formulations, augmented with Apigenin, Oleanolic Acid, and Biotinoyl Tripeptide-1.
• Contract Development and Manufacturing Organization (CDMO) Services Global CDMO providing pre-formulation and formulation development, analytical development, ICH stability studies, and cGMP manufacturing for partners in regulated markets including UK, Europe, Australia, and New Zealand, with specialization in differentiated products, complex generics, fixed-dose combinations, and OTC products.

Quantifiable outcome

• 34 years of trusted brand leadership with Cypon (Cyproheptadine) - No.1 brand of Cyproheptadine
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Hyosung (South Korea)coreTechnology or Integration · 18 May 2026Geno's fermentation technology is licensed to Hyosung for converting Brazilian sugarcane sugars into bio-based 1,4-Butanediol (Bio-BDO). Geno provides the biotechnology platform for renewable chemical production using sugarcane feedstock.
• Goa Bagayatdar Sahakari Kharedi Vikri Saunstha MaryaditminorOthersPartnership for food grains distribution to needy and underprivileged people in Goa. The government cooperative society facilitated smooth distribution of food grains donated by Geno.
• Rotary Club of Mapusa CityminorStrategic or Co-development PartnerAssociation with Geno Foundation for handing over medical equipment to North Goa Collector for Shyama Prasad Specialty Covid Care Center.
• IMA Bardez BranchminorStrategic or Co-development PartnerCollaboration for providing oxygen concentrators to ST Joseph Covid Care Centre at Old Goa through Geno Foundation.
• Partners in UK and EuropecoreChannel Partner/ Reseller/ DistributorStrategic partnerships with pharmaceutical companies in UK and Europe for CDMO services and pharmaceutical product supply to regulated markets.

Scale indicators4 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Cipla: One of India's largest pharma manufacturers with deep domestic distribution and a strong branded generics + international generics franchise across Africa, Asia, and regulated markets. Directly comparable to Geno as an Indian-headquartered, multi-division pharma with similar therapeutic breadth and African/Asian market focus.
• Mankind Pharma: Top-tier Indian pharma with a domestic-focused, field-sales-driven branded generics model. Highly comparable GTM motion (large field force, multi-therapeutic coverage) and similar primary care/general medicine positioning to Geno's Shakti division.
• Torrent Pharmaceuticals: Mid-to-large Indian pharma with strong domestic branded generics presence, dermatology segment, and growing CDMO/international business. Directly comparable scale and therapeutic mix, including dermatology overlap with Geno's Clean Care division.
• Alkem Laboratories: Indian pharma with broad therapeutic coverage, anti-infectives franchise, and growing international presence. Comparable on domestic distribution depth, branded generics focus, and emerging regulated-market CDMO strategy.
• Ipca Laboratories: Indian pharma specializing in anti-infectives, pain management, and dermatology with significant API+formulation integration. Comparable therapeutic focus, formulation capabilities, and emerging international CDMO presence to Geno.
• Ajanta Pharma: Mid-sized Indian pharma with strong branded generics presence in India and Africa, plus dermatology and emerging regulated-market businesses. Closely comparable to Geno on geography mix (India + Africa) and therapeutic categories.

Broad incumbents

• Lupin: One of India's largest pharma companies with broad domestic and international footprint, including US generics, branded India, and CDMO services. Larger scale than Geno but directly comparable in therapeutic breadth and multi-geography branded generics model.
• Dr. Reddy's Laboratories: Major Indian pharma with strong global generics, biosimilars, and CDMO operations across regulated and emerging markets. Overlaps with Geno on CDMO services, Indian branded generics, and emerging-market distribution model.
• Aurobindo Pharma: Large Indian pharma with leading global generics presence and significant CDMO capacity. Comparable CDMO positioning and international regulated-market strategy, though at materially larger scale than Geno.
• Sun Pharmaceutical Industries: India's largest pharma company with global specialty, generics, and consumer healthcare operations. Comparable therapeutic breadth and dermatology presence via Clean Care-like consumer brands, but at vastly larger scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks2 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Geno